Exagen (XGN) Income from Continuing Operations (2018 - 2026)
Exagen's (XGN) quarterly Income from Continuing Operations came in at 3967000.0 in Q1 2026, down 5.73% YoY from 4208137.97 in Q1 2025, and up 15.11% on a QoQ basis from 4673000.0 in Q4 2025.
Exagen (XGN) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Exagen (XGN) has 9 years of Income from Continuing Operations data on file, last reported at 3967000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 5.73% year-over-year to 3967000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20166000.0 (down 30.04% YoY) and the FY2025 annual result came in at 19951000.0, down 31.99% from the prior year.
- Income from Continuing Operations rose to 3967000.0 in Q1 2026, from 4673000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 2966000.0 in Q2 2024 to a low of 17325000.0 in Q1 2022.
- A 5-year average of 7079941.18 and a median of 5028000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 179.03% — and 2023, when it soared 69.94%.
- Tracing XGN's Income from Continuing Operations over 5 years: stood at 14401000.0 in 2022, then jumped by 62.68% to 5375000.0 in 2023, then jumped by 30.03% to 3761000.0 in 2024, then retreated by 24.25% to 4673000.0 in 2025, then climbed by 15.11% to 3967000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 3967000.0 (Q1 2026), 4673000.0 (Q4 2025), and 7087000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Exagen | 181.48 Mn | 156.88 Mn | 12.22 Mn | -3.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.20 Mn |
| Mar 31, 2026 | -3.97 Mn |
| Dec 31, 2025 | -4.67 Mn |
| Sep 30, 2025 | -7.09 Mn |
| Jun 30, 2025 | -4.44 Mn |
| Mar 31, 2025 | -3.75 Mn |
| Dec 31, 2024 | -3.76 Mn |
| Sep 30, 2024 | -5.03 Mn |
| Jun 30, 2024 | -2.97 Mn |
| Mar 31, 2024 | -3.36 Mn |
| Dec 31, 2023 | -5.54 Mn |
| Sep 30, 2023 | -5.42 Mn |
| Jun 30, 2023 | -5.01 Mn |
| Mar 31, 2023 | -7.69 Mn |
| Dec 31, 2022 | -15.12 Mn |
| Sep 30, 2022 | -8.44 Mn |
| Jun 30, 2022 | -14.67 Mn |
| Mar 31, 2022 | -10.27 Mn |
| Dec 31, 2021 | -7.05 Mn |
| Sep 30, 2021 | -7.18 Mn |